UY33128A - PIRIDINONE DERIVATIVES AND PHARMACEUTICAL COMPOSITIONS OF THE SAME - Google Patents

PIRIDINONE DERIVATIVES AND PHARMACEUTICAL COMPOSITIONS OF THE SAME

Info

Publication number
UY33128A
UY33128A UY33128A UY33128A UY33128A UY 33128 A UY33128 A UY 33128A UY 33128 A UY33128 A UY 33128A UY 33128 A UY33128 A UY 33128A UY 33128 A UY33128 A UY 33128A
Authority
UY
Uruguay
Prior art keywords
piridinone
derivatives
same
pharmaceutical compositions
pharmaceutical
Prior art date
Application number
UY33128A
Other languages
Spanish (es)
Inventor
Jan Huebner
Christof Wegscheid-Gerlach
Olaf Panknin
Sven Ring
Stefan Baurle
Christoph Huwe
Katrin Nowak
Reinhard Nubbemeyer
Hans-Peter Muhn
Original Assignee
Bayer Schering Pharma Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Schering Pharma Ag filed Critical Bayer Schering Pharma Ag
Publication of UY33128A publication Critical patent/UY33128A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/02—Drugs for disorders of the endocrine system of the hypothalamic hormones, e.g. TRH, GnRH, CRH, GRH, somatostatin
    • A61P5/04—Drugs for disorders of the endocrine system of the hypothalamic hormones, e.g. TRH, GnRH, CRH, GRH, somatostatin for decreasing, blocking or antagonising the activity of the hypothalamic hormones
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D498/04—Ortho-condensed systems

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Immunology (AREA)
  • Diabetes (AREA)
  • Reproductive Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
UY33128A 2009-12-22 2010-12-21 PIRIDINONE DERIVATIVES AND PHARMACEUTICAL COMPOSITIONS OF THE SAME UY33128A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP09075567 2009-12-22

Publications (1)

Publication Number Publication Date
UY33128A true UY33128A (en) 2011-07-29

Family

ID=42076929

Family Applications (1)

Application Number Title Priority Date Filing Date
UY33128A UY33128A (en) 2009-12-22 2010-12-21 PIRIDINONE DERIVATIVES AND PHARMACEUTICAL COMPOSITIONS OF THE SAME

Country Status (4)

Country Link
AR (1) AR079688A1 (en)
TW (1) TW201130854A (en)
UY (1) UY33128A (en)
WO (1) WO2011076687A1 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2012175514A1 (en) * 2011-06-21 2012-12-27 Bayer Intellectual Property Gmbh Pyridinone derivatives and pharmaceutical compositions thereof
WO2014185853A1 (en) * 2013-05-14 2014-11-20 Quretech Bio Ab Compounds and methods for treatment of chlamydia infections
ES2747839T3 (en) 2013-10-30 2020-03-11 Shanghai hengrui pharmaceutical co ltd Pyrazolopyrimidone or pyrrolotriazone derivatives, method of preparation thereof, and pharmaceutical applications thereof
EP2881391A1 (en) 2013-12-05 2015-06-10 Bayer Pharma Aktiengesellschaft Spiroindoline carbocycle derivatives and pharmaceutical compositions thereof
JP2017529388A (en) 2014-08-26 2017-10-05 ベタニエン ホスピタル Methods, agents and compositions for the treatment of inflammatory conditions
PT3539545T (en) 2016-11-14 2021-09-06 Jiangsu Hengrui Medicine Co Crystalline form of gnrh receptor antagonist and preparation method therefor

Family Cites Families (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2213510A1 (en) 1995-06-01 1996-12-05 Takeda Chemical Industries, Ltd. Diazepinones, their production and use
WO1997014697A1 (en) 1995-10-19 1997-04-24 Takeda Chemical Industries, Ltd. Thienopyridine derivatives as gonadotropin releasing hormone antagonists
CA2229201A1 (en) 1995-10-19 1997-04-24 Satoshi Sasaki Quinoline derivatives, their production and use
WO1997021704A1 (en) 1995-12-14 1997-06-19 Merck & Co., Inc. Antagonists of gonadotropin releasing hormone
US5780437A (en) 1995-12-14 1998-07-14 Merck & Co., Inc. Antagonists of gonadotropin releasing hormone
US5849764A (en) 1995-12-14 1998-12-15 Merck & Co., Inc. Antagonists of gonadotropin releasing hormone
AU707277B2 (en) 1995-12-14 1999-07-08 Merck & Co., Inc. Antagonists of gonadotropin releasing hormone
WO1997021435A1 (en) 1995-12-14 1997-06-19 Merck & Co., Inc. Antagonists of gonadotropin releasing hormone
KR19990072124A (en) 1995-12-14 1999-09-27 애쉬톤 왈레이스 티 Antagonists of gonadotropin releasing hormone
EP0920319A4 (en) 1996-05-20 2002-05-02 Merck & Co Inc Antagonists of gonadotropin releasing hormone
JP2000511532A (en) 1996-05-20 2000-09-05 メルク エンド カンパニー インコーポレーテッド Gonadotropin-releasing hormone antagonists
AU3071397A (en) 1996-05-20 1997-12-09 Merck & Co., Inc. Antagonists of gonadotropin releasing hormone
CA2254768A1 (en) 1996-05-20 1997-11-27 Jinlong Jiang Antagonists of gonadotropin releasing hormone
WO1998005511A1 (en) 1996-08-01 1998-02-12 Igaz Denes Method for marking objects
EP0986385A4 (en) 1997-06-05 2001-05-16 Merck & Co Inc Antagonists of gonadotropin releasing hormone
AU729752B2 (en) 1997-06-05 2001-02-08 Merck & Co., Inc. Antagonists of gonadotropin releasing hormone
CA2291647A1 (en) 1997-06-05 1998-12-10 Merck & Co., Inc. Antagonists of gonadotropin releasing hormone
US6313301B1 (en) 1997-08-13 2001-11-06 Takeda Chemical Industries, Ltd. Thienopyridine derivatives, their intermediates and production thereof
CA2300479A1 (en) 1997-12-26 1999-07-08 Shuichi Furuya Nitrogen-containing heterocyclic compounds, their production and use
US20020065309A1 (en) 1999-08-04 2002-05-30 Ge Peng Novel Bicyclic and tricyclic pyrrolidine derivatives as GnRH antagonists
CA2386942A1 (en) 1999-10-15 2001-04-26 Neurocrine Biosciences, Inc. Gonadotropin-releasing hormone receptor antagonists and methods relating thereto
EP1233967A4 (en) 1999-11-19 2003-07-09 Univ Washington Pyridinones to treat and prevent bacterial infections
WO2001055119A2 (en) 2000-01-25 2001-08-02 Neurocrine Biosciences, Inc. Gonadotropin-releasing hormone receptor antagonists and methods relating thereto
EP1393747A4 (en) * 2000-04-13 2004-03-03 Takeda Chemical Industries Ltd Preventives/remedies for alzheimer's disease
SE0100566D0 (en) 2001-02-20 2001-02-20 Astrazeneca Ab Compounds
US6939883B2 (en) 2001-08-02 2005-09-06 Neurocrine Biosciences, Inc. Gonadotropin-releasing hormone receptor antagonists and methods relating thereto
AU2002321878A1 (en) 2001-08-02 2003-02-17 Neurocrine Biosciences, Inc. Pyridinone and pyridazinone derivatives as gonadotropin-releasing hormone receptor antagonists
US6740656B2 (en) 2001-08-02 2004-05-25 Neurocrine Biosciences, Inc. Gonadotropin-releasing hormone receptor antagonists and methods relating thereto
AU2002324586B2 (en) 2001-08-02 2008-04-24 Neurocrine Biosciences, Inc. 1,3,5-triazine-2,4,6-triones, preparation and use as gonadotropin-releasing hormone receptor antagonists
MXPA04000986A (en) 2001-08-02 2005-02-17 Neurocrine Biosciences Inc 1,2,4-triazin-3,5-diones as gonadotropin-releasing hormone receptor (gnrh) antagonists.
AU2004257636B2 (en) 2003-07-07 2011-01-06 Neurocrine Biosciences, Inc. Pyrimidine-2,4-dione derivatives as gonadotropin-releasing hormone receptor antagonists
CN101384604B (en) 2006-02-15 2012-08-08 埃科特莱茵药品有限公司 Ethanol or 1,2-ethanediol cyclohexyl antibiotic derivatives
AR063417A1 (en) 2006-11-01 2009-01-28 Astrazeneca Ab INHIBITING COMPOUNDS OF TYPE 1 PLASMINOGEN ACTIVATOR (PAI-1)
SI2137196T1 (en) 2007-04-20 2011-01-31 Glaxo Group Ltd Glaxo Welcome House Tricyclic nitrogen containing compounds as antibacterial agents

Also Published As

Publication number Publication date
AR079688A1 (en) 2012-02-15
TW201130854A (en) 2011-09-16
WO2011076687A1 (en) 2011-06-30

Similar Documents

Publication Publication Date Title
SMT201600350B (en) PHARMACEUTICAL COMPOSITIONS
IL224976A (en) Substituted 1h-indazole derivatives and pharmaceutical compositions comprising them
BRPI0906980A2 (en) Composition of derivatives and maleatados
BRPI1011587A2 (en) therapeutic compounds and compositions
DK3097925T3 (en) PHARMACEUTICAL COMPOSITION
IL199853A (en) Substituted derivatives of 5-hydroxy-adamantyl-2-yl and pharmaceutical compositions comprising them
BRPI1013642A2 (en) triazine derivative and pharmaceutical composition comprising the same
BRPI1004940A2 (en) pharmaceutical composition
SMT201400069B (en) Pharmaceutical formulation
IL224288A (en) Derivatives of substituted pyrazolamide, pharmaceutical compositions comprising the same and uses thereof
DK2395834T3 (en) SODIUM NITRIT-CONTAINING PHARMACEUTICAL COMPOSITIONS
BRPI1012539A2 (en) pharmaceutical compositions
BRPI0918206A2 (en) animoester derivatives and medicinal composition of these
DK3492069T3 (en) PHARMACEUTICAL COMPOSITIONS INCLUDING IRON-OXY-HYDROXIDE
BRPI1015939A2 (en) pharmaceutical composition
SMT201400155B (en) Pharmaceutical compositions comprising derivatives of 2-oxo-1-pyrrolidine
CR10665A (en) NEW DERIVATIVES OF DIOSMETINE, ITS PREPARATION PROCEDURE AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
IT1394400B1 (en) PHARMACEUTICAL COMPOSITIONS
DK2654736T3 (en) Unknown pharmaceutical composition
SMT201600076B (en) DERIVATIVES OF 2-BONE-1-PYRROLIDINYL IMIDAZOTIADIAZOL
DK2391351T3 (en) Pharmaceutical composition comprising 2-oxo-1-pyrrolidine derivatives
BRPI1014688A2 (en) therapeutic applications of quinazolinadione derivatives
CO6801722A2 (en) Pharmaceutical compositions
BRPI0820198A2 (en) pharmaceutical compositions
BR112012001340A2 (en) pharmaceutical compositions

Legal Events

Date Code Title Description
109 Application deemed to be withdrawn

Effective date: 20181127